Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
10.49
-0.93 (-8.12%)
At close: Jul 8, 2026, 4:00 PM EDT
10.54
+0.05 (0.45%)
After-hours: Jul 8, 2026, 7:10 PM EDT
Company Description
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico.
It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers.
The company is based in Toronto, Canada.
Akanda Corp.
| Country | Canada |
| Founded | 2021 |
| IPO Date | Mar 15, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Katharyn Field |
Contact Details
Address: 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 Canada | |
| Phone | 416-862-7525 |
| Website | akandacorp.com |
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 1888014 |
| CUSIP Number | 00971M700 |
| ISIN Number | CA00971M7008 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Interim Chief Executive Officer and Executive Director |
| Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2026 | 6-K | Report of foreign issuer |
| Jun 12, 2026 | 6-K | Report of foreign issuer |
| Jun 9, 2026 | 20-F | Annual and transition report of foreign private issuers |
| May 22, 2026 | 6-K | Report of foreign issuer |
| May 13, 2026 | 6-K | Report of foreign issuer |
| May 1, 2026 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 29, 2026 | 6-K | Report of foreign issuer |
| Apr 10, 2026 | 6-K | Report of foreign issuer |
| Apr 9, 2026 | 6-K | Report of foreign issuer |
| Apr 7, 2026 | 6-K | Report of foreign issuer |